리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 07월
페이지 정보:영문 391 Pages
라이선스 & 가격 (부가세 별도)
한글목차
소프트젤 캡슐 세계 시장은 2030년까지 미국에서 114억 달러에 달할 전망
2024년에 85억 달러로 추정되는 소프트젤 캡슐 세계 시장은 2024년부터 2030년까지 CAGR 5.0%로 성장하여 2030년에는 114억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 젤라틴 기반/동물 기반은 CAGR 4.1%를 기록하며 분석 기간 종료시에는 74억 달러에 달할 것으로 예측됩니다. 비동물성 부문의 성장률은 분석 기간 동안 CAGR 6.9%로 추정됩니다.
미국 시장은 23억 달러로 추정, 중국은 CAGR 7.8%로 성장할 것으로 예측
미국의 소프트젤 캡슐 시장은 2024년에 23억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년 분석 기간 동안 CAGR 7.8%로 성장하여 2030년까지 22억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 2.5%와 5.0%로 예측됩니다. 유럽에서는 독일이 CAGR 3.2%로 성장할 것으로 예측됩니다.
세계 소프트젤 캡슐 시장 - 주요 동향 및 촉진요인 정리
소프트젤 캡슐이 시장에서 인기를 끌고 있는 이유는 무엇일까? 의약품, 건강보조식품, 화장품에서 소프트젤 캡슐의 역할에 대한 이해
소프트젤 캡슐은 복용의 용이성, 생체 이용률의 향상, 보존 기간의 연장으로 인해 의약품, 건강보조식품 및 화장품 산업에서 선호되는 제형입니다. 기존의 정제나 경질 캡슐과 달리, 소프트젤 캡슐은 젤라틴 기반 쉘에 액체 또는 반고체 제제를 캡슐화하여 안정성이 향상되고 흡수가 더 잘됩니다. 지용성 비타민, 오메가 3 지방산, 허브 추출물, 처방약 등의 전달에 널리 사용됩니다. 편리하고 맛이 없는 경구용 제형에 대한 소비자의 선호도가 높아지면서 소프트젤 캡슐에 대한 수요가 더욱 증가하고 있습니다. 또한, 특히 면역력 향상 및 노화 방지 제품을 찾는 건강 지향적 소비자들 사이에서 건강보조식품의 소비가 확대되고 있는 것도 시장을 강화시키고 있습니다. 제약 업계도 약물 방출을 제어하고 환자의 순응도를 높이기 위해 소프트젤 기술을 활용하여 현대 의학에서 지배적인 경구용 제형으로서의 입지를 강화하고 있습니다.
기술 혁신은 소프트젤 캡슐 제조를 어떻게 강화하고 있는가? 캡슐화 및 제형 과학의 발전을 탐구하다
소프트젤 캡슐 산업에서는 캡슐화 기술과 제형 과학이 크게 발전하여 제품의 품질과 다양성이 향상되고 있습니다. 식물성 하이드로콜로이드 및 카라기난과 같은 젤라틴 대체물의 혁신은 비건 및 채식주의자 개발로 이어져 식이 제한이 있는 소비자층의 증가에 대응하고 있습니다. 또한, 마이크로캡슐화 기술의 발전으로 유효 성분의 안정성과 생체 이용률이 향상되어 소프트젤 캡슐은 보다 효과적인 약물전달이 가능해졌습니다. 또한, 장용성 코팅 소프트젤의 도입으로 지연 방출 제제가 가능해져 최적의 흡수를 보장하고 위장 자극을 줄일 수 있게 되었습니다. 자동화와 연속 생산 공정으로 생산 효율성이 더욱 합리화되어 제약 및 건강보조식품 회사는 비용을 절감하고 확장성을 향상시킬 수 있습니다. 소프트젤 캡슐의 제형을 개선하는 연구가 진행됨에 따라 업계는 새로운 치료 및 기능성 용도로 확대될 것으로 예상됩니다.
소프트젤 캡슐 시장에 영향을 미치는 이슈는? 원재료 비용, 규제 준수, 보관 안정성 대응
소프트젤 캡슐의 인기가 높아지고 있지만, 원료 비용, 엄격한 규제 요건, 안정성에 대한 도전에 직면해 있습니다. 동물성 젤라틴을 사용하기 때문에 공급망의 지속가능성과 가격 변동에 대한 우려가 있습니다. 또한, 지역마다 규제 상황이 다르기 때문에 제조업체는 엄격한 품질 관리 및 라벨링 기준을 충족해야 합니다. 안정성 문제, 특히 습기에 민감한 제형과 열에 민감한 제형도 소프트젤의 제조 및 보관에 대한 도전과제가 되고 있습니다. 이러한 문제를 해결하기 위해서는 대체 캡슐 소재에 대한 투자, 진화하는 의약품 규제에 대한 대응, 제품의 내구성을 향상시키는 안정성 향상 부형제의 발전이 필요합니다.
소프트젤 캡슐 시장의 성장을 촉진하는 요인은 무엇일까? 주요 산업 확장 동향과 소비자 선호도 파악하기
소프트젤 캡슐 시장의 성장은 건강보조식품에 대한 소비자 수요 증가, 캡슐화 기술의 발전, 의약품의 환자 친화적 제형 채택 증가 등 여러 요인에 의해 주도되고 있습니다. 건강 지향적인 라이프스타일의 급격한 증가는 특히 신흥국 시장에서 소프트젤 기반의 비타민, 미네랄, 허브 보충제 소비를 촉진하고 있습니다. 또한, 기능성 식품과 코스메슈티컬의 확대는 미용 및 스킨케어 제품에 소프트젤을 활용할 수 있는 새로운 기회를 제공하고 있습니다. 진통제, 심혈관계, 항염증제에 대한 제약 부문의 소프트젤 선호도는 시장 성장을 더욱 강화하고 있습니다. 캡슐 설계 및 성분 안정성에 대한 지속적인 기술 혁신으로 인해 소프트젤 캡슐 시장은 지속적으로 확대될 것으로 예상되며, 소비자와 의료 서비스 제공자에게 신뢰할 수 있고 효율적인 약물전달 솔루션을 제공하고 있습니다.
Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.
Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트
기타 중동
아프리카
제4장 경쟁
ksm
영문 목차
영문목차
Global Softgel Capsules Market to Reach US$11.4 Billion by 2030
The global market for Softgel Capsules estimated at US$8.5 Billion in the year 2024, is expected to reach US$11.4 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Gelatin-based / Animal-based, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$7.4 Billion by the end of the analysis period. Growth in the Non-Animal-based segment is estimated at 6.9% CAGR over the analysis period.
The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 7.8% CAGR
The Softgel Capsules market in the U.S. is estimated at US$2.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.
Global Softgel Capsules Market - Key Trends & Drivers Summarized
Why Are Softgel Capsules Gaining Market Popularity? Understanding Their Role in Pharmaceuticals, Nutraceuticals, and Cosmetics
Softgel capsules have become a preferred dosage form in the pharmaceutical, nutraceutical, and cosmetic industries due to their ease of consumption, enhanced bioavailability, and extended shelf life. Unlike traditional tablets or hard capsules, softgel capsules encapsulate liquid or semi-solid formulations in a gelatin-based shell, offering improved stability and better absorption. They are widely used for delivering fat-soluble vitamins, omega-3 fatty acids, herbal extracts, and prescription medications. The growing consumer preference for convenient and tasteless oral dosage forms has further fueled the demand for softgel capsules. Additionally, the expansion of dietary supplement consumption, particularly among health-conscious consumers seeking immunity-boosting and anti-aging products, has strengthened the market. The pharmaceutical industry has also leveraged softgel technology for controlled drug release and improved patient compliance, reinforcing its position as a dominant oral dosage form in modern medicine.
How Are Technological Innovations Enhancing Softgel Capsule Manufacturing? Exploring Advancements in Encapsulation and Formulation Science
The softgel capsule industry has witnessed significant advancements in encapsulation techniques and formulation science, improving product quality and versatility. Innovations in gelatin alternatives, such as plant-based hydrocolloids and carrageenan, have led to the development of vegan and vegetarian softgel capsules, catering to a growing segment of consumers with dietary restrictions. Additionally, advances in microencapsulation technology have enhanced the stability and bioavailability of active ingredients, making softgel capsules more effective for targeted drug delivery. The introduction of enteric-coated softgels has also allowed for delayed release formulations, ensuring optimal absorption and reducing gastric irritation. Automation and continuous manufacturing processes have further streamlined production efficiency, reducing costs and improving scalability for pharmaceutical and nutraceutical companies. As research continues to refine softgel capsule formulations, the industry is expected to expand into new therapeutic and functional applications.
What Challenges Are Affecting the Softgel Capsules Market? Addressing Raw Material Costs, Regulatory Compliance, and Shelf Stability
Despite their growing popularity, softgel capsules face challenges related to raw material costs, strict regulatory requirements, and stability concerns. The use of gelatin, derived from animal sources, has raised concerns over supply chain sustainability and pricing fluctuations. Additionally, the regulatory landscape for softgel capsules varies across different regions, requiring manufacturers to meet stringent quality control and labeling standards. Stability issues, particularly for moisture-sensitive or heat-sensitive formulations, have also posed challenges in softgel manufacturing and storage. Addressing these concerns requires investments in alternative capsule materials, compliance with evolving pharmaceutical regulations, and advancements in stability-enhancing excipients to improve product durability.
What’s Driving the Growth of the Softgel Capsules Market? Identifying Key Industry Expansion Trends and Consumer Preferences
The growth in the softgel capsules market is driven by several factors, including increasing consumer demand for nutritional supplements, advancements in encapsulation technology, and rising adoption of patient-friendly dosage forms in pharmaceuticals. The surge in health-conscious lifestyles has encouraged the consumption of softgel-based vitamins, minerals, and herbal supplements, particularly in developed markets. Additionally, the expansion of functional foods and cosmeceuticals has introduced new opportunities for softgel delivery in beauty and skincare products. The pharmaceutical sector’s preference for softgels in pain relief, cardiovascular, and anti-inflammatory medications has further strengthened market growth. With continuous innovation in capsule design and ingredient stability, the softgel capsules market is expected to see sustained expansion, offering consumers and healthcare providers a reliable and efficient drug delivery solution.
SCOPE OF STUDY:
The report analyzes the Softgel Capsules market in terms of units by the following Segments, and Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 43 Featured) -
Aenova Group GmbH
Algen Healthcare
Biborick Pharma
Biofield Pharma
Capsugel (Lonza)
CAPTEK Softgel International Inc.
Catalent, Inc.
Curivo Healthcare
Curtis Health Caps
Delpharm Evreux
Emcure Pharmaceuticals Limited
Estrellus
EuroCaps Ltd
Fuji Capsule Co., Ltd.
Greenwell Lifesciences
Guangdong Yichao Biological Co., Ltd.
Hunan ER-KANG Pharmaceutical Co Ltd
KD Pharma Group
Lifecare Neuro Products Ltd
Lifevision Healthcare
MEDGEL Private Limited
Olive Healthcare
Procaps Group
Saphnix Life Sciences
Sirio Pharma Company Ltd
Soft Gel Technologies, Inc.
Strides Pharma Science Limited
Swisschem Healthcare
Windzor Pharma Ltd
ZYUS Life Sciences Inc.
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Softgel Capsules - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for Easy-to-Swallow, Bioavailable Oral Dosage Forms Throws the Spotlight on Softgel Capsules
Growth in Nutraceutical and OTC Supplement Market Spurs Consumption of Softgel-Based Delivery Systems
OEM Innovation in Gelatin and Vegan Alternative Shells Expands Consumer Acceptance and Market Reach
Expansion of Oil-Based APIs and Lipophilic Actives Supports Formulation in Softgel Format
OEM Emphasis on Controlled Release, Enteric Coating, and Odor Masking Enhances Drug Stability
Increasing Use in Omega-3, Vitamins, and Herbal Extract Supplements Supports Daily Health Product Demand
OEM Development of Twin-Shell, Liquid-Fill, and Semi-Solid Formulations Drives Product Customization
Rising Consumer Preference for Transparent Capsules and Clean Label Claims Supports Natural Formulation Trends
OEM Integration of High-Speed Encapsulation, Leak-Proof Sealing, and Uniform Fill Weight Enhances Quality Control
Growth in Contract Manufacturing Services Supports Small and Medium Brand Entry Into Competitive Markets
OEM Focus on Advanced Printing and Brand Differentiation Technologies Enhances Market Visibility
Expansion of Pediatric and Geriatric Therapeutics Supports Use in Non-Chewable, Taste-Masked Delivery
OEM Partnerships With Nutraceutical and Functional Food Brands Accelerate Launch of New SKUs
Rising Demand for Shelf-Stable, Moisture-Protected Supplements Strengthens Blister and Bottle Packaging Innovation
OEM Strategies for Multi-Compartment Capsules and Dual Action Therapies Support Complex Formulations
Surge in Personalized Supplementation Models Supports Small Batch, Custom Softgel Production
OEM Investment in Kosher, Halal, and Non-GMO Certifications Enhances Global Export Potential
Growth in Cold-Pressed Oils, CBD, and Botanical Oils Supports Use of Oil-Soluble Fill Formats
OEM Emphasis on Global Regulatory Compliance, Gelatin Sourcing Transparency, and BSE-Free Supply Chains Strengthens Trust
Focus on Digestive Comfort, Quick Absorption, and Dose Uniformity Enhances Softgel Preference Over Tablets
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Softgel Capsules Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Softgel Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Softgel Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Softgel Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Gelatin-based / Animal-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Gelatin-based / Animal-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Gelatin-based / Animal-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Non-Animal-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Non-Animal-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Non-Animal-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Pregnancy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Pregnancy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Pregnancy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Antacid & Anti-Flatulent Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Antacid & Anti-Flatulent Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Antacid & Anti-Flatulent Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Anti-Anemic Preparations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Anti-Anemic Preparations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Anti-Anemic Preparations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for Anti-Inflammatory Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Antibiotic & Antibacterial Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for Antibiotic & Antibacterial Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 25: World 15-Year Perspective for Antibiotic & Antibacterial Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Cough & Cold Preparations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 27: World Historic Review for Cough & Cold Preparations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 28: World 15-Year Perspective for Cough & Cold Preparations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Health Supplement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 30: World Historic Review for Health Supplement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 31: World 15-Year Perspective for Health Supplement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Vitamin & Dietary Supplement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 33: World Historic Review for Vitamin & Dietary Supplement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 34: World 15-Year Perspective for Vitamin & Dietary Supplement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 36: World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 37: World 15-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Nutraceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 39: World Historic Review for Nutraceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 40: World 15-Year Perspective for Nutraceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 41: World Recent Past, Current & Future Analysis for Cosmeceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 42: World Historic Review for Cosmeceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 43: World 15-Year Perspective for Cosmeceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 44: World Recent Past, Current & Future Analysis for Contract Manufacturing Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 45: World Historic Review for Contract Manufacturing Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 46: World 15-Year Perspective for Contract Manufacturing Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 47: USA Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 48: USA Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 49: USA 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 50: USA Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: USA Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 52: USA 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 53: USA Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: USA Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 55: USA 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
CANADA
TABLE 56: Canada Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: Canada Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 58: Canada 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 59: Canada Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 60: Canada Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 61: Canada 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 62: Canada Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Canada Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 64: Canada 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
JAPAN
Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 65: Japan Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: Japan Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 67: Japan 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 68: Japan Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: Japan Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 70: Japan 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 71: Japan Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: Japan Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 73: Japan 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
CHINA
Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 74: China Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: China Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 76: China 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 77: China Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: China Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 79: China 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 80: China Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: China Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 82: China 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
EUROPE
Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 83: Europe Recent Past, Current & Future Analysis for Softgel Capsules by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Softgel Capsules by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 85: Europe 15-Year Perspective for Softgel Capsules by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 86: Europe Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Europe Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 88: Europe 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 89: Europe Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: Europe Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 91: Europe 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 92: Europe Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Europe Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 94: Europe 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
FRANCE
Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 95: France Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 96: France Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 97: France 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 98: France Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: France Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 100: France 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 101: France Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: France Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 103: France 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
GERMANY
Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 104: Germany Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Germany Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 106: Germany 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 107: Germany Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 108: Germany Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 109: Germany 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 110: Germany Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: Germany Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 112: Germany 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
ITALY
TABLE 113: Italy Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 114: Italy Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 115: Italy 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 116: Italy Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: Italy Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 118: Italy 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 119: Italy Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 120: Italy Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 121: Italy 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
UNITED KINGDOM
Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 122: UK Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 123: UK Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 124: UK 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 125: UK Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 126: UK Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 127: UK 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 128: UK Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 129: UK Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 130: UK 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
SPAIN
TABLE 131: Spain Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 132: Spain Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 133: Spain 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 134: Spain Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 135: Spain Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 136: Spain 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 137: Spain Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 138: Spain Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 139: Spain 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
RUSSIA
TABLE 140: Russia Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 141: Russia Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 142: Russia 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 143: Russia Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 144: Russia Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 145: Russia 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 146: Russia Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 147: Russia Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 148: Russia 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 150: Rest of Europe Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 151: Rest of Europe 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 153: Rest of Europe Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 154: Rest of Europe 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 156: Rest of Europe Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 157: Rest of Europe 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 159: Asia-Pacific Historic Review for Softgel Capsules by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 160: Asia-Pacific 15-Year Perspective for Softgel Capsules by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 162: Asia-Pacific Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 163: Asia-Pacific 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 165: Asia-Pacific Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 166: Asia-Pacific 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 168: Asia-Pacific Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 169: Asia-Pacific 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
AUSTRALIA
Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 170: Australia Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 171: Australia Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 172: Australia 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 173: Australia Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 174: Australia Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 175: Australia 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 176: Australia Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 177: Australia Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 178: Australia 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
INDIA
Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 179: India Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 180: India Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 181: India 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 182: India Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 183: India Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 184: India 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 185: India Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 186: India Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 187: India 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
SOUTH KOREA
TABLE 188: South Korea Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 189: South Korea Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 190: South Korea 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 191: South Korea Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 192: South Korea Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 193: South Korea 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 194: South Korea Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 195: South Korea Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 196: South Korea 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 198: Rest of Asia-Pacific Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 201: Rest of Asia-Pacific Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 204: Rest of Asia-Pacific Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
LATIN AMERICA
Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 206: Latin America Recent Past, Current & Future Analysis for Softgel Capsules by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 207: Latin America Historic Review for Softgel Capsules by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 208: Latin America 15-Year Perspective for Softgel Capsules by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
TABLE 209: Latin America Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 210: Latin America Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 211: Latin America 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 212: Latin America Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 213: Latin America Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 214: Latin America 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 215: Latin America Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 216: Latin America Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 217: Latin America 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
ARGENTINA
TABLE 218: Argentina Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 219: Argentina Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 220: Argentina 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 221: Argentina Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 222: Argentina Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 223: Argentina 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 224: Argentina Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 225: Argentina Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 226: Argentina 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
BRAZIL
TABLE 227: Brazil Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 228: Brazil Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 229: Brazil 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 230: Brazil Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 231: Brazil Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 232: Brazil 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 233: Brazil Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 234: Brazil Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 235: Brazil 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
MEXICO
TABLE 236: Mexico Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 237: Mexico Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 238: Mexico 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 239: Mexico Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 240: Mexico Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 241: Mexico 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 242: Mexico Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 243: Mexico Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 244: Mexico 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 246: Rest of Latin America Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 247: Rest of Latin America 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 249: Rest of Latin America Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 250: Rest of Latin America 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 252: Rest of Latin America Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 253: Rest of Latin America 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
MIDDLE EAST
Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 254: Middle East Recent Past, Current & Future Analysis for Softgel Capsules by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 255: Middle East Historic Review for Softgel Capsules by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 256: Middle East 15-Year Perspective for Softgel Capsules by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
TABLE 257: Middle East Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 258: Middle East Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 259: Middle East 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 260: Middle East Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 261: Middle East Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 262: Middle East 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 263: Middle East Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 264: Middle East Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 265: Middle East 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
IRAN
TABLE 266: Iran Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 267: Iran Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 268: Iran 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 269: Iran Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 270: Iran Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 271: Iran 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 272: Iran Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 273: Iran Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 274: Iran 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
ISRAEL
TABLE 275: Israel Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 276: Israel Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 277: Israel 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 278: Israel Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 279: Israel Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 280: Israel 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 281: Israel Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 282: Israel Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 283: Israel 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
SAUDI ARABIA
TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 285: Saudi Arabia Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 286: Saudi Arabia 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 288: Saudi Arabia Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 289: Saudi Arabia 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 291: Saudi Arabia Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 292: Saudi Arabia 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 293: UAE Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 294: UAE Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 295: UAE 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 296: UAE Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 297: UAE Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 298: UAE 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 299: UAE Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 300: UAE Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 301: UAE 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 303: Rest of Middle East Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 304: Rest of Middle East 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 306: Rest of Middle East Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 307: Rest of Middle East 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 309: Rest of Middle East Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 310: Rest of Middle East 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030
AFRICA
Softgel Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 311: Africa Recent Past, Current & Future Analysis for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 312: Africa Historic Review for Softgel Capsules by Type - Gelatin-based / Animal-based and Non-Animal-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 313: Africa 15-Year Perspective for Softgel Capsules by Type - Percentage Breakdown of Value Sales for Gelatin-based / Animal-based and Non-Animal-based for the Years 2015, 2025 & 2030
TABLE 314: Africa Recent Past, Current & Future Analysis for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 315: Africa Historic Review for Softgel Capsules by Application - Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 316: Africa 15-Year Perspective for Softgel Capsules by Application - Percentage Breakdown of Value Sales for Pregnancy, Antacid & Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic & Antibacterial Drugs, Cough & Cold Preparations, Health Supplement and Vitamin & Dietary Supplement for the Years 2015, 2025 & 2030
TABLE 317: Africa Recent Past, Current & Future Analysis for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 318: Africa Historic Review for Softgel Capsules by End-Use - Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 319: Africa 15-Year Perspective for Softgel Capsules by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Contract Manufacturing Organizations for the Years 2015, 2025 & 2030